US biotech Passage Bio (Nasdaq: PASG) has agreed an all-stock reverse merger with RNA specialist Remix Therapeutics, giving the private company a route onto Nasdaq and fresh capital to push its lead ...
Guard Therapeutics International AB (publ) ("Guard Therapeutics" or the "Company") has today entered into a conditional agreement with shareholders who together hold approximately 91.3 percent of all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results